Liver Transplant Outcomes with ’Marginal’ and Benchmark Allografts Similar
Study findings encourage aggressive use of liver allografts Outcomes among liver transplant...
Read MoreAug 6, 2020
Study findings encourage aggressive use of liver allografts Outcomes among liver transplant...
Read MoreMay 27, 2020
New research was presented at AATS 2020, the virtual Annual Meeting of the American Association...
Read MoreMay 27, 2020
Mitigating geographic disparities not enough Sex-based inequities in access to liver transplants won’t necessarily be solved by just enacting policies designed to mitigate geographic disparities in liver allocations.In...
Read MoreMay 15, 2020
Small series points to complex issues for HT patients with Covid-19 Over an 8-week period...
Read MoreApr 20, 2020
Trial tested approach against antiviral prophylaxis in CMV-seronegative recipients Using preemptive therapy led to a lower incidence of cytomegalovirus (CMV) disease over 12 months in CMV-seronegative liver transplant recipients...
Read MoreApr 20, 2020
Trial tested approach against antiviral prophylaxis in CMV-seronegative recipients Using preemptive therapy led to a lower incidence of cytomegalovirus (CMV) disease over 12 months in CMV-seronegative liver transplant recipients...
Read MoreApr 16, 2020
Trial tested approach against antiviral prophylaxis in CMV-seronegative recipients Using preemptive therapy led to a lower incidence of cytomegalovirus (CMV) disease over 12 months in CMV-seronegative liver transplant recipients...
Read MoreApr 16, 2020
Trial tested approach against antiviral prophylaxis in CMV-seronegative recipients Using preemptive therapy led to a lower incidence of cytomegalovirus (CMV) disease over 12 months in CMV-seronegative liver transplant recipients...
Read More